This clinical trial will test the effect of NeuroAD, a noninvasive device that delivers magnetic stimulation to the brain, on cognition in people with mild to moderate Alzheimer's disease.
|Min Age||Max Age||Gender||Healthy Volunteers|
This clinical trial will test NeuroAD, a noninvasive system of transcranial magnetic stimulation and cognitive training, as a way to improve cognitive function in people with mild to moderate Alzheimer's disease. Potential participants will undergo screening procedures to confirm eligibility to participate in the study, followed by randomization to either the experimental treatment group or the placebo group, which will receive treatment with a sham device. Individuals will visit the clinic five times a week for 6 weeks, approximately an hour every day for treatment, then return for a follow-up visit.
|Map Marker||City||State||Zip Code||Status||Primary Contact|
Geolocation is 33.6020658, -112.280129
Geolocation is 33.6834142, -117.9073244
Geolocation is 25.8207159, -80.1819268
Geolocation is 27.4081935, -82.5294065
Geolocation is 26.7619563, -80.1037721
West Palm Beach
Geolocation is 42.3476181, -71.1002881
Geolocation is 36.1922841, -115.1592718
Geolocation is 40.74727, -73.9800645
Geolocation is 41.4836446, -81.806039
Charlie Bernick, MD
Lou Ruvo Brain Center